Medartis Holding Past Earnings Performance
Past criteria checks 1/6
Medartis Holding's earnings have been declining at an average annual rate of -16.9%, while the Medical Equipment industry saw earnings growing at 10.6% annually. Revenues have been growing at an average rate of 13.2% per year. Medartis Holding's return on equity is 1.5%, and it has net margins of 1.8%.
Key information
-16.9%
Earnings growth rate
-17.7%
EPS growth rate
| Medical Equipment Industry Growth | 11.1% |
| Revenue growth rate | 13.2% |
| Return on equity | 1.5% |
| Net Margin | 1.8% |
| Next Earnings Update | 18 Mar 2025 |
Recent past performance updates
Recent updates
A Piece Of The Puzzle Missing From Medartis Holding AG's (VTX:MED) Share Price
Nov 27
Medartis Holding (VTX:MED) Has A Rock Solid Balance Sheet
Nov 09The Strong Earnings Posted By Medartis Holding (VTX:MED) Are A Good Indication Of The Strength Of The Business
Aug 27Medartis Holding AG (VTX:MED) Doing What It Can To Lift Shares
Aug 21When Should You Buy Medartis Holding AG (VTX:MED)?
May 10Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation
Apr 11The Returns On Capital At Medartis Holding (VTX:MED) Don't Inspire Confidence
Feb 14Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around
Oct 24Is Medartis Holding (VTX:MED) A Risky Investment?
Oct 03Is Medartis Holding AG (VTX:MED) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 06Market Still Lacking Some Conviction On Medartis Holding AG (VTX:MED)
Jun 21Medartis Holding (VTX:MED) May Have Issues Allocating Its Capital
Jan 31Why Medartis Holding AG (VTX:MED) Could Be Worth Watching
Oct 30These Analysts Think Medartis Holding AG's (VTX:MED) Sales Are Under Threat
Sep 07When Should You Buy Medartis Holding AG (VTX:MED)?
Jul 29Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital
May 06At CHF123, Is It Time To Put Medartis Holding AG (VTX:MED) On Your Watch List?
Feb 08Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around
Jan 18We Think Medartis Holding (VTX:MED) Can Stay On Top Of Its Debt
Nov 10Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital
Sep 29Some Investors May Be Worried About Medartis Holding's (VTX:MED) Returns On Capital
Jun 08How Much Of Medartis Holding AG (VTX:MED) Do Insiders Own?
Mar 16We're Watching These Trends At Medartis Holding (VTX:MED)
Feb 09
Medartis Holding (VTX:MED) Shareholders Have Enjoyed A 10% Share Price Gain
Jan 04What Type Of Shareholders Own The Most Number of Medartis Holding AG (VTX:MED) Shares?
Nov 19Revenue & Expenses Breakdown
How Medartis Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 220 | 4 | 138 | 35 |
| 31 Mar 24 | 216 | 2 | 134 | 30 |
| 31 Dec 23 | 212 | 1 | 130 | 26 |
| 30 Sep 23 | 205 | -3 | 130 | 26 |
| 30 Jun 23 | 198 | -7 | 129 | 27 |
| 31 Mar 23 | 190 | -6 | 128 | 26 |
| 31 Dec 22 | 183 | -6 | 126 | 25 |
| 30 Sep 22 | 178 | -3 | 121 | 23 |
| 30 Jun 22 | 173 | 0 | 116 | 22 |
| 31 Mar 22 | 166 | 3 | 110 | 21 |
| 31 Dec 21 | 160 | 7 | 103 | 20 |
| 30 Sep 21 | 153 | 9 | 98 | 19 |
| 30 Jun 21 | 146 | 12 | 94 | 19 |
| 31 Mar 21 | 137 | 6 | 90 | 18 |
| 31 Dec 20 | 128 | -1 | 87 | 16 |
| 30 Sep 20 | 125 | -3 | 87 | 15 |
| 30 Jun 20 | 123 | -4 | 86 | 15 |
| 31 Mar 20 | 126 | -1 | 88 | 15 |
| 31 Dec 19 | 130 | 2 | 89 | 15 |
| 30 Sep 19 | 127 | 3 | 87 | 14 |
| 30 Jun 19 | 125 | 4 | 84 | 14 |
| 31 Mar 19 | 123 | 4 | 83 | 14 |
| 31 Dec 18 | 121 | 4 | 82 | 13 |
| 30 Sep 18 | 119 | 2 | 80 | 13 |
| 30 Jun 18 | 116 | 0 | 78 | 13 |
| 31 Mar 18 | 111 | 0 | 72 | 12 |
| 31 Dec 17 | 105 | 1 | 67 | 11 |
| 31 Dec 16 | 93 | 3 | 54 | 9 |
| 31 Dec 15 | 82 | 7 | 47 | 9 |
Quality Earnings: MED has a large one-off loss of CHF3.1M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: MED became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MED's earnings have declined by 16.9% per year over the past 5 years.
Accelerating Growth: MED has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: MED has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-1.6%).
Return on Equity
High ROE: MED's Return on Equity (1.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 11:46 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medartis Holding AG is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eric Le Berrigaud | Bryan Garnier & Co |
| Hugo Solvet | Bryan Garnier & Co |
| Christoph Gretler | Credit Suisse |